12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant movement in Thursday's after-market session. Regulus Therapeutics, SeqLL, bioAffinity Technologies, Enveric Biosciences, Blue Water Biotech, and China Pharma Holding saw gains, while Baudax Bio, Surrozen, TransCode Therapeutics, IGC Pharma, Taysha Gene Therapies, and TRACON Pharma experienced losses.
September 21, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
bioAffinity Technologies shares moved upwards by 9.43% to $1.16.
The stock price increased significantly in the after-market session, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Blue Water Biotech shares rose 8.67% to $0.61.
The stock price increased significantly in the after-market session, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
China Pharma Holding stock rose 7.01% to $0.14.
The stock price increased significantly in the after-market session, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Enveric Biosciences shares increased by 9.05% to $2.65.
The stock price increased significantly in the after-market session, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Regulus Therapeutics stock increased by 12.4% to $1.45 during Thursday's after-market session.
The stock price increased significantly in the after-market session, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
SeqLL shares moved upwards by 10.34% to $15.79.
The stock price increased significantly in the after-market session, indicating positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Baudax Bio shares decreased by 10.1% to $0.31 during Thursday's after-market session.
The stock price decreased significantly in the after-market session, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
IGC Pharma stock fell 5.33% to $0.37.
The stock price decreased significantly in the after-market session, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
TransCode Therapeutics stock decreased by 6.45% to $0.65.
The stock price decreased significantly in the after-market session, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Surrozen stock declined by 6.49% to $0.43.
The stock price decreased significantly in the after-market session, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
TRACON Pharma stock decreased by 4.57% to $0.21.
The stock price decreased significantly in the after-market session, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Taysha Gene Therapies stock declined by 4.63% to $2.89.
The stock price decreased significantly in the after-market session, indicating negative investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100